Global Atrial Fibrillation Surgery Market
Global Atrial Fibrillation Surgery Market

Atrial Fibrillation Surgery Comprehensive Study by Type (Ablation Surgeries (Radiofrequency Ablation, Sonar, Microwave, Cryoablation), Atrioventricular Node Ablation, Maze Procedure), Application (Mitral Stenosis, Hyperthyroidism, High Blood Pressure, Pulmonary Embolus, Pneumonia), Devices (Maze Surgery, Catheter Ablation) Players and Region - Global Market Outlook to 2024

Atrial Fibrillation Surgery Market Segmented into XX Submarkets. | Forecast Years: 2019- 2024  

Jun 2019 Edition 237 Pages 200 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
Industry Background:
Atrial fibrillation is a condition involves abnormal heartbeat. There are different types of surgeries used to treat atrial fibrillation. There is the development of atrial fibrillation ablation technologies which aims for reducing the need for repeat procedures and to reduce procedure times. There are different treatment options for managing A-fib, including lifestyle changes, medications, and other nonsurgical options. While these treatments may help some people, they may not work for everybody and are not a cure. Doctors may consider surgery if a patient's medications aren't working and when nothing else has helped.This growth is primarily driven by Rise in Generality of Atrial Fibrillation in Geriatric Population and Technology Advancement.

Globally, a noticeable market trend is evident High Preference of Catheter Ablation for Cardiac Arrhythmia Treatment. Major Players, such as Biosense Webster Inc. (United States), Medtronic plc (Ireland), Abbott Laboratories (United States), Boston Scientific Corporation (United States), AtriCure Inc. (United States), Biotronik SE & Co. KG (Germany), Cardiofocus Inc. (United States) and Johnsons & Johnson Ltd (United States) etc have either set up their manufacturing facilities or are planning to start new provision in the dominated region in the upcoming years.

In Jan 2019, Abbott Announced United States Food And Drug Administration (FDA) Approval Of The Tacticath Contact Force Ablation Catheter Sensor Enabled, A New Ablation Catheter Designed To Help Physicians Accurately And Effectively Treat Atrial Fibrillation. Additionally In Jan 2019 Nebraska Medicine Disclosed a Study Which Define New Surgical Procedure Improves Outcomes for Most Advanced Atrial Fibrillation Cases

Market Drivers
  • Rise in Generality of Atrial Fibrillation in Geriatric Population
  • Technology Advancement

Market Trend
  • High Preference of Catheter Ablation for Cardiac Arrhythmia Treatment

Restraints
  • Unfavourable Preference for Pharmaceutical Interventions (Drugs) Over Atrial Fibrillation Surgeries Is Hamper the Growth of the Market


Challenges
Some Side Effects Include Mild Pain, Bleeding, Bruising, Vein Problems

AdvanceMarketAnalytics follow a focused and realistic research framework that provides the ability to study the crucial market dynamics in several regions across the world. Moreover, an in-depth assessment is mostly conducted by our analysts on geographical regions to provide clients and businesses the opportunity to dominate in niche markets and expand in emerging markets across the globe. This market research study also showcase the spontaneously changing Players landscape impacting the growth of the market. Furthermore, our market researchers extensively analyse the products and services offered by multiple players competing to increase their market share and presence.

Customization of the Report:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase
Report Objectives / Segmentation Covered
By Type
  • Ablation Surgeries (Radiofrequency Ablation, Sonar, Microwave, Cryoablation)
  • Atrioventricular Node Ablation
  • Maze Procedure
By Application
  • Mitral Stenosis
  • Hyperthyroidism
  • High Blood Pressure
  • Pulmonary Embolus
  • Pneumonia
By Devices
  • Maze Surgery
  • Catheter Ablation

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Rise in Generality of Atrial Fibrillation in Geriatric Population
      • 3.2.2. Technology Advancement
    • 3.3. Market Challenges
      • 3.3.1. Some Side Effects Include Mild Pain, Bleeding, Bruising, Vein Problems
    • 3.4. Market Trends
      • 3.4.1. High Preference of Catheter Ablation for Cardiac Arrhythmia Treatment
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Atrial Fibrillation Surgery, by Type, Application, Devices and Region (value) (2013-2018)
    • 5.1. Introduction
    • 5.2. Global Atrial Fibrillation Surgery (Value)
      • 5.2.1. Global Atrial Fibrillation Surgery by: Type (Value)
        • 5.2.1.1. Ablation Surgeries (Radiofrequency Ablation, Sonar, Microwave, Cryoablation)
        • 5.2.1.2. Atrioventricular Node Ablation
        • 5.2.1.3. Maze Procedure
      • 5.2.2. Global Atrial Fibrillation Surgery by: Application (Value)
        • 5.2.2.1. Mitral Stenosis
        • 5.2.2.2. Hyperthyroidism
        • 5.2.2.3. High Blood Pressure
        • 5.2.2.4. Pulmonary Embolus
        • 5.2.2.5. Pneumonia
      • 5.2.3. Global Atrial Fibrillation Surgery by: Devices (Value)
        • 5.2.3.1. Maze Surgery
        • 5.2.3.2. Catheter Ablation
      • 5.2.4. Global Atrial Fibrillation Surgery Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
  • 6. Atrial Fibrillation Surgery: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2018)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Biosense Webster Inc. (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Medtronic plc (Ireland)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Abbott Laboratories (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Boston Scientific Corporation (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. AtriCure Inc. (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Biotronik SE & Co. KG (Germany)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Cardiofocus Inc. (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Johnsons & Johnson Ltd (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
  • 7. Global Atrial Fibrillation Surgery Sale, by Type, Application, Devices and Region (value) (2019-2024)
    • 7.1. Introduction
    • 7.2. Global Atrial Fibrillation Surgery (Value)
      • 7.2.1. Global Atrial Fibrillation Surgery by: Type (Value)
        • 7.2.1.1. Ablation Surgeries (Radiofrequency Ablation, Sonar, Microwave, Cryoablation)
        • 7.2.1.2. Atrioventricular Node Ablation
        • 7.2.1.3. Maze Procedure
      • 7.2.2. Global Atrial Fibrillation Surgery by: Application (Value)
        • 7.2.2.1. Mitral Stenosis
        • 7.2.2.2. Hyperthyroidism
        • 7.2.2.3. High Blood Pressure
        • 7.2.2.4. Pulmonary Embolus
        • 7.2.2.5. Pneumonia
      • 7.2.3. Global Atrial Fibrillation Surgery by: Devices (Value)
        • 7.2.3.1. Maze Surgery
        • 7.2.3.2. Catheter Ablation
      • 7.2.4. Global Atrial Fibrillation Surgery Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Atrial Fibrillation Surgery: by Type(USD Million)
  • Table 2. Atrial Fibrillation Surgery Ablation Surgeries (Radiofrequency Ablation, Sonar, Microwave, Cryoablation) , by Region USD Million (2013-2018)
  • Table 3. Atrial Fibrillation Surgery Atrioventricular Node Ablation , by Region USD Million (2013-2018)
  • Table 4. Atrial Fibrillation Surgery Maze Procedure , by Region USD Million (2013-2018)
  • Table 5. Atrial Fibrillation Surgery: by Application(USD Million)
  • Table 6. Atrial Fibrillation Surgery Mitral Stenosis , by Region USD Million (2013-2018)
  • Table 7. Atrial Fibrillation Surgery Hyperthyroidism , by Region USD Million (2013-2018)
  • Table 8. Atrial Fibrillation Surgery High Blood Pressure , by Region USD Million (2013-2018)
  • Table 9. Atrial Fibrillation Surgery Pulmonary Embolus , by Region USD Million (2013-2018)
  • Table 10. Atrial Fibrillation Surgery Pneumonia , by Region USD Million (2013-2018)
  • Table 11. Atrial Fibrillation Surgery: by Devices(USD Million)
  • Table 12. Atrial Fibrillation Surgery Maze Surgery , by Region USD Million (2013-2018)
  • Table 13. Atrial Fibrillation Surgery Catheter Ablation , by Region USD Million (2013-2018)
  • Table 14. South America Atrial Fibrillation Surgery, by Country USD Million (2013-2018)
  • Table 15. South America Atrial Fibrillation Surgery, by Type USD Million (2013-2018)
  • Table 16. South America Atrial Fibrillation Surgery, by Application USD Million (2013-2018)
  • Table 17. South America Atrial Fibrillation Surgery, by Devices USD Million (2013-2018)
  • Table 18. Brazil Atrial Fibrillation Surgery, by Type USD Million (2013-2018)
  • Table 19. Brazil Atrial Fibrillation Surgery, by Application USD Million (2013-2018)
  • Table 20. Brazil Atrial Fibrillation Surgery, by Devices USD Million (2013-2018)
  • Table 21. Argentina Atrial Fibrillation Surgery, by Type USD Million (2013-2018)
  • Table 22. Argentina Atrial Fibrillation Surgery, by Application USD Million (2013-2018)
  • Table 23. Argentina Atrial Fibrillation Surgery, by Devices USD Million (2013-2018)
  • Table 24. Rest of South America Atrial Fibrillation Surgery, by Type USD Million (2013-2018)
  • Table 25. Rest of South America Atrial Fibrillation Surgery, by Application USD Million (2013-2018)
  • Table 26. Rest of South America Atrial Fibrillation Surgery, by Devices USD Million (2013-2018)
  • Table 27. Asia Pacific Atrial Fibrillation Surgery, by Country USD Million (2013-2018)
  • Table 28. Asia Pacific Atrial Fibrillation Surgery, by Type USD Million (2013-2018)
  • Table 29. Asia Pacific Atrial Fibrillation Surgery, by Application USD Million (2013-2018)
  • Table 30. Asia Pacific Atrial Fibrillation Surgery, by Devices USD Million (2013-2018)
  • Table 31. China Atrial Fibrillation Surgery, by Type USD Million (2013-2018)
  • Table 32. China Atrial Fibrillation Surgery, by Application USD Million (2013-2018)
  • Table 33. China Atrial Fibrillation Surgery, by Devices USD Million (2013-2018)
  • Table 34. Japan Atrial Fibrillation Surgery, by Type USD Million (2013-2018)
  • Table 35. Japan Atrial Fibrillation Surgery, by Application USD Million (2013-2018)
  • Table 36. Japan Atrial Fibrillation Surgery, by Devices USD Million (2013-2018)
  • Table 37. India Atrial Fibrillation Surgery, by Type USD Million (2013-2018)
  • Table 38. India Atrial Fibrillation Surgery, by Application USD Million (2013-2018)
  • Table 39. India Atrial Fibrillation Surgery, by Devices USD Million (2013-2018)
  • Table 40. South Korea Atrial Fibrillation Surgery, by Type USD Million (2013-2018)
  • Table 41. South Korea Atrial Fibrillation Surgery, by Application USD Million (2013-2018)
  • Table 42. South Korea Atrial Fibrillation Surgery, by Devices USD Million (2013-2018)
  • Table 43. Taiwan Atrial Fibrillation Surgery, by Type USD Million (2013-2018)
  • Table 44. Taiwan Atrial Fibrillation Surgery, by Application USD Million (2013-2018)
  • Table 45. Taiwan Atrial Fibrillation Surgery, by Devices USD Million (2013-2018)
  • Table 46. Australia Atrial Fibrillation Surgery, by Type USD Million (2013-2018)
  • Table 47. Australia Atrial Fibrillation Surgery, by Application USD Million (2013-2018)
  • Table 48. Australia Atrial Fibrillation Surgery, by Devices USD Million (2013-2018)
  • Table 49. Rest of Asia-Pacific Atrial Fibrillation Surgery, by Type USD Million (2013-2018)
  • Table 50. Rest of Asia-Pacific Atrial Fibrillation Surgery, by Application USD Million (2013-2018)
  • Table 51. Rest of Asia-Pacific Atrial Fibrillation Surgery, by Devices USD Million (2013-2018)
  • Table 52. Europe Atrial Fibrillation Surgery, by Country USD Million (2013-2018)
  • Table 53. Europe Atrial Fibrillation Surgery, by Type USD Million (2013-2018)
  • Table 54. Europe Atrial Fibrillation Surgery, by Application USD Million (2013-2018)
  • Table 55. Europe Atrial Fibrillation Surgery, by Devices USD Million (2013-2018)
  • Table 56. Germany Atrial Fibrillation Surgery, by Type USD Million (2013-2018)
  • Table 57. Germany Atrial Fibrillation Surgery, by Application USD Million (2013-2018)
  • Table 58. Germany Atrial Fibrillation Surgery, by Devices USD Million (2013-2018)
  • Table 59. France Atrial Fibrillation Surgery, by Type USD Million (2013-2018)
  • Table 60. France Atrial Fibrillation Surgery, by Application USD Million (2013-2018)
  • Table 61. France Atrial Fibrillation Surgery, by Devices USD Million (2013-2018)
  • Table 62. Italy Atrial Fibrillation Surgery, by Type USD Million (2013-2018)
  • Table 63. Italy Atrial Fibrillation Surgery, by Application USD Million (2013-2018)
  • Table 64. Italy Atrial Fibrillation Surgery, by Devices USD Million (2013-2018)
  • Table 65. United Kingdom Atrial Fibrillation Surgery, by Type USD Million (2013-2018)
  • Table 66. United Kingdom Atrial Fibrillation Surgery, by Application USD Million (2013-2018)
  • Table 67. United Kingdom Atrial Fibrillation Surgery, by Devices USD Million (2013-2018)
  • Table 68. Netherlands Atrial Fibrillation Surgery, by Type USD Million (2013-2018)
  • Table 69. Netherlands Atrial Fibrillation Surgery, by Application USD Million (2013-2018)
  • Table 70. Netherlands Atrial Fibrillation Surgery, by Devices USD Million (2013-2018)
  • Table 71. Rest of Europe Atrial Fibrillation Surgery, by Type USD Million (2013-2018)
  • Table 72. Rest of Europe Atrial Fibrillation Surgery, by Application USD Million (2013-2018)
  • Table 73. Rest of Europe Atrial Fibrillation Surgery, by Devices USD Million (2013-2018)
  • Table 74. MEA Atrial Fibrillation Surgery, by Country USD Million (2013-2018)
  • Table 75. MEA Atrial Fibrillation Surgery, by Type USD Million (2013-2018)
  • Table 76. MEA Atrial Fibrillation Surgery, by Application USD Million (2013-2018)
  • Table 77. MEA Atrial Fibrillation Surgery, by Devices USD Million (2013-2018)
  • Table 78. Middle East Atrial Fibrillation Surgery, by Type USD Million (2013-2018)
  • Table 79. Middle East Atrial Fibrillation Surgery, by Application USD Million (2013-2018)
  • Table 80. Middle East Atrial Fibrillation Surgery, by Devices USD Million (2013-2018)
  • Table 81. Africa Atrial Fibrillation Surgery, by Type USD Million (2013-2018)
  • Table 82. Africa Atrial Fibrillation Surgery, by Application USD Million (2013-2018)
  • Table 83. Africa Atrial Fibrillation Surgery, by Devices USD Million (2013-2018)
  • Table 84. North America Atrial Fibrillation Surgery, by Country USD Million (2013-2018)
  • Table 85. North America Atrial Fibrillation Surgery, by Type USD Million (2013-2018)
  • Table 86. North America Atrial Fibrillation Surgery, by Application USD Million (2013-2018)
  • Table 87. North America Atrial Fibrillation Surgery, by Devices USD Million (2013-2018)
  • Table 88. United States Atrial Fibrillation Surgery, by Type USD Million (2013-2018)
  • Table 89. United States Atrial Fibrillation Surgery, by Application USD Million (2013-2018)
  • Table 90. United States Atrial Fibrillation Surgery, by Devices USD Million (2013-2018)
  • Table 91. Canada Atrial Fibrillation Surgery, by Type USD Million (2013-2018)
  • Table 92. Canada Atrial Fibrillation Surgery, by Application USD Million (2013-2018)
  • Table 93. Canada Atrial Fibrillation Surgery, by Devices USD Million (2013-2018)
  • Table 94. Mexico Atrial Fibrillation Surgery, by Type USD Million (2013-2018)
  • Table 95. Mexico Atrial Fibrillation Surgery, by Application USD Million (2013-2018)
  • Table 96. Mexico Atrial Fibrillation Surgery, by Devices USD Million (2013-2018)
  • Table 97. Company Basic Information, Sales Area and Its Competitors
  • Table 98. Company Basic Information, Sales Area and Its Competitors
  • Table 99. Company Basic Information, Sales Area and Its Competitors
  • Table 100. Company Basic Information, Sales Area and Its Competitors
  • Table 101. Company Basic Information, Sales Area and Its Competitors
  • Table 102. Company Basic Information, Sales Area and Its Competitors
  • Table 103. Company Basic Information, Sales Area and Its Competitors
  • Table 104. Company Basic Information, Sales Area and Its Competitors
  • Table 105. Atrial Fibrillation Surgery: by Type(USD Million)
  • Table 106. Atrial Fibrillation Surgery Ablation Surgeries (Radiofrequency Ablation, Sonar, Microwave, Cryoablation) , by Region USD Million (2019-2024)
  • Table 107. Atrial Fibrillation Surgery Atrioventricular Node Ablation , by Region USD Million (2019-2024)
  • Table 108. Atrial Fibrillation Surgery Maze Procedure , by Region USD Million (2019-2024)
  • Table 109. Atrial Fibrillation Surgery: by Application(USD Million)
  • Table 110. Atrial Fibrillation Surgery Mitral Stenosis , by Region USD Million (2019-2024)
  • Table 111. Atrial Fibrillation Surgery Hyperthyroidism , by Region USD Million (2019-2024)
  • Table 112. Atrial Fibrillation Surgery High Blood Pressure , by Region USD Million (2019-2024)
  • Table 113. Atrial Fibrillation Surgery Pulmonary Embolus , by Region USD Million (2019-2024)
  • Table 114. Atrial Fibrillation Surgery Pneumonia , by Region USD Million (2019-2024)
  • Table 115. Atrial Fibrillation Surgery: by Devices(USD Million)
  • Table 116. Atrial Fibrillation Surgery Maze Surgery , by Region USD Million (2019-2024)
  • Table 117. Atrial Fibrillation Surgery Catheter Ablation , by Region USD Million (2019-2024)
  • Table 118. South America Atrial Fibrillation Surgery, by Country USD Million (2019-2024)
  • Table 119. South America Atrial Fibrillation Surgery, by Type USD Million (2019-2024)
  • Table 120. South America Atrial Fibrillation Surgery, by Application USD Million (2019-2024)
  • Table 121. South America Atrial Fibrillation Surgery, by Devices USD Million (2019-2024)
  • Table 122. Brazil Atrial Fibrillation Surgery, by Type USD Million (2019-2024)
  • Table 123. Brazil Atrial Fibrillation Surgery, by Application USD Million (2019-2024)
  • Table 124. Brazil Atrial Fibrillation Surgery, by Devices USD Million (2019-2024)
  • Table 125. Argentina Atrial Fibrillation Surgery, by Type USD Million (2019-2024)
  • Table 126. Argentina Atrial Fibrillation Surgery, by Application USD Million (2019-2024)
  • Table 127. Argentina Atrial Fibrillation Surgery, by Devices USD Million (2019-2024)
  • Table 128. Rest of South America Atrial Fibrillation Surgery, by Type USD Million (2019-2024)
  • Table 129. Rest of South America Atrial Fibrillation Surgery, by Application USD Million (2019-2024)
  • Table 130. Rest of South America Atrial Fibrillation Surgery, by Devices USD Million (2019-2024)
  • Table 131. Asia Pacific Atrial Fibrillation Surgery, by Country USD Million (2019-2024)
  • Table 132. Asia Pacific Atrial Fibrillation Surgery, by Type USD Million (2019-2024)
  • Table 133. Asia Pacific Atrial Fibrillation Surgery, by Application USD Million (2019-2024)
  • Table 134. Asia Pacific Atrial Fibrillation Surgery, by Devices USD Million (2019-2024)
  • Table 135. China Atrial Fibrillation Surgery, by Type USD Million (2019-2024)
  • Table 136. China Atrial Fibrillation Surgery, by Application USD Million (2019-2024)
  • Table 137. China Atrial Fibrillation Surgery, by Devices USD Million (2019-2024)
  • Table 138. Japan Atrial Fibrillation Surgery, by Type USD Million (2019-2024)
  • Table 139. Japan Atrial Fibrillation Surgery, by Application USD Million (2019-2024)
  • Table 140. Japan Atrial Fibrillation Surgery, by Devices USD Million (2019-2024)
  • Table 141. India Atrial Fibrillation Surgery, by Type USD Million (2019-2024)
  • Table 142. India Atrial Fibrillation Surgery, by Application USD Million (2019-2024)
  • Table 143. India Atrial Fibrillation Surgery, by Devices USD Million (2019-2024)
  • Table 144. South Korea Atrial Fibrillation Surgery, by Type USD Million (2019-2024)
  • Table 145. South Korea Atrial Fibrillation Surgery, by Application USD Million (2019-2024)
  • Table 146. South Korea Atrial Fibrillation Surgery, by Devices USD Million (2019-2024)
  • Table 147. Taiwan Atrial Fibrillation Surgery, by Type USD Million (2019-2024)
  • Table 148. Taiwan Atrial Fibrillation Surgery, by Application USD Million (2019-2024)
  • Table 149. Taiwan Atrial Fibrillation Surgery, by Devices USD Million (2019-2024)
  • Table 150. Australia Atrial Fibrillation Surgery, by Type USD Million (2019-2024)
  • Table 151. Australia Atrial Fibrillation Surgery, by Application USD Million (2019-2024)
  • Table 152. Australia Atrial Fibrillation Surgery, by Devices USD Million (2019-2024)
  • Table 153. Rest of Asia-Pacific Atrial Fibrillation Surgery, by Type USD Million (2019-2024)
  • Table 154. Rest of Asia-Pacific Atrial Fibrillation Surgery, by Application USD Million (2019-2024)
  • Table 155. Rest of Asia-Pacific Atrial Fibrillation Surgery, by Devices USD Million (2019-2024)
  • Table 156. Europe Atrial Fibrillation Surgery, by Country USD Million (2019-2024)
  • Table 157. Europe Atrial Fibrillation Surgery, by Type USD Million (2019-2024)
  • Table 158. Europe Atrial Fibrillation Surgery, by Application USD Million (2019-2024)
  • Table 159. Europe Atrial Fibrillation Surgery, by Devices USD Million (2019-2024)
  • Table 160. Germany Atrial Fibrillation Surgery, by Type USD Million (2019-2024)
  • Table 161. Germany Atrial Fibrillation Surgery, by Application USD Million (2019-2024)
  • Table 162. Germany Atrial Fibrillation Surgery, by Devices USD Million (2019-2024)
  • Table 163. France Atrial Fibrillation Surgery, by Type USD Million (2019-2024)
  • Table 164. France Atrial Fibrillation Surgery, by Application USD Million (2019-2024)
  • Table 165. France Atrial Fibrillation Surgery, by Devices USD Million (2019-2024)
  • Table 166. Italy Atrial Fibrillation Surgery, by Type USD Million (2019-2024)
  • Table 167. Italy Atrial Fibrillation Surgery, by Application USD Million (2019-2024)
  • Table 168. Italy Atrial Fibrillation Surgery, by Devices USD Million (2019-2024)
  • Table 169. United Kingdom Atrial Fibrillation Surgery, by Type USD Million (2019-2024)
  • Table 170. United Kingdom Atrial Fibrillation Surgery, by Application USD Million (2019-2024)
  • Table 171. United Kingdom Atrial Fibrillation Surgery, by Devices USD Million (2019-2024)
  • Table 172. Netherlands Atrial Fibrillation Surgery, by Type USD Million (2019-2024)
  • Table 173. Netherlands Atrial Fibrillation Surgery, by Application USD Million (2019-2024)
  • Table 174. Netherlands Atrial Fibrillation Surgery, by Devices USD Million (2019-2024)
  • Table 175. Rest of Europe Atrial Fibrillation Surgery, by Type USD Million (2019-2024)
  • Table 176. Rest of Europe Atrial Fibrillation Surgery, by Application USD Million (2019-2024)
  • Table 177. Rest of Europe Atrial Fibrillation Surgery, by Devices USD Million (2019-2024)
  • Table 178. MEA Atrial Fibrillation Surgery, by Country USD Million (2019-2024)
  • Table 179. MEA Atrial Fibrillation Surgery, by Type USD Million (2019-2024)
  • Table 180. MEA Atrial Fibrillation Surgery, by Application USD Million (2019-2024)
  • Table 181. MEA Atrial Fibrillation Surgery, by Devices USD Million (2019-2024)
  • Table 182. Middle East Atrial Fibrillation Surgery, by Type USD Million (2019-2024)
  • Table 183. Middle East Atrial Fibrillation Surgery, by Application USD Million (2019-2024)
  • Table 184. Middle East Atrial Fibrillation Surgery, by Devices USD Million (2019-2024)
  • Table 185. Africa Atrial Fibrillation Surgery, by Type USD Million (2019-2024)
  • Table 186. Africa Atrial Fibrillation Surgery, by Application USD Million (2019-2024)
  • Table 187. Africa Atrial Fibrillation Surgery, by Devices USD Million (2019-2024)
  • Table 188. North America Atrial Fibrillation Surgery, by Country USD Million (2019-2024)
  • Table 189. North America Atrial Fibrillation Surgery, by Type USD Million (2019-2024)
  • Table 190. North America Atrial Fibrillation Surgery, by Application USD Million (2019-2024)
  • Table 191. North America Atrial Fibrillation Surgery, by Devices USD Million (2019-2024)
  • Table 192. United States Atrial Fibrillation Surgery, by Type USD Million (2019-2024)
  • Table 193. United States Atrial Fibrillation Surgery, by Application USD Million (2019-2024)
  • Table 194. United States Atrial Fibrillation Surgery, by Devices USD Million (2019-2024)
  • Table 195. Canada Atrial Fibrillation Surgery, by Type USD Million (2019-2024)
  • Table 196. Canada Atrial Fibrillation Surgery, by Application USD Million (2019-2024)
  • Table 197. Canada Atrial Fibrillation Surgery, by Devices USD Million (2019-2024)
  • Table 198. Mexico Atrial Fibrillation Surgery, by Type USD Million (2019-2024)
  • Table 199. Mexico Atrial Fibrillation Surgery, by Application USD Million (2019-2024)
  • Table 200. Mexico Atrial Fibrillation Surgery, by Devices USD Million (2019-2024)
  • Table 201. Research Programs/Design for This Report
  • Table 202. Key Data Information from Secondary Sources
  • Table 203. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Atrial Fibrillation Surgery: by Type USD Million (2013-2018)
  • Figure 5. Global Atrial Fibrillation Surgery: by Application USD Million (2013-2018)
  • Figure 6. Global Atrial Fibrillation Surgery: by Devices USD Million (2013-2018)
  • Figure 7. South America Atrial Fibrillation Surgery Share (%), by Country
  • Figure 8. Asia Pacific Atrial Fibrillation Surgery Share (%), by Country
  • Figure 9. Europe Atrial Fibrillation Surgery Share (%), by Country
  • Figure 10. MEA Atrial Fibrillation Surgery Share (%), by Country
  • Figure 11. North America Atrial Fibrillation Surgery Share (%), by Country
  • Figure 12. Global Atrial Fibrillation Surgery share by Players 2018 (%)
  • Figure 13. Global Atrial Fibrillation Surgery share by Players (Top 3) 2018(%)
  • Figure 14. Global Atrial Fibrillation Surgery share by Players (Top 5) 2018(%)
  • Figure 15. BCG Matrix for key Companies
  • Figure 16. Biosense Webster Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 17. Biosense Webster Inc. (United States) Revenue: by Geography 2018
  • Figure 18. Medtronic plc (Ireland) Revenue, Net Income and Gross profit
  • Figure 19. Medtronic plc (Ireland) Revenue: by Geography 2018
  • Figure 20. Abbott Laboratories (United States) Revenue, Net Income and Gross profit
  • Figure 21. Abbott Laboratories (United States) Revenue: by Geography 2018
  • Figure 22. Boston Scientific Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 23. Boston Scientific Corporation (United States) Revenue: by Geography 2018
  • Figure 24. AtriCure Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 25. AtriCure Inc. (United States) Revenue: by Geography 2018
  • Figure 26. Biotronik SE & Co. KG (Germany) Revenue, Net Income and Gross profit
  • Figure 27. Biotronik SE & Co. KG (Germany) Revenue: by Geography 2018
  • Figure 28. Cardiofocus Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 29. Cardiofocus Inc. (United States) Revenue: by Geography 2018
  • Figure 30. Johnsons & Johnson Ltd (United States) Revenue, Net Income and Gross profit
  • Figure 31. Johnsons & Johnson Ltd (United States) Revenue: by Geography 2018
  • Figure 32. Global Atrial Fibrillation Surgery: by Type USD Million (2019-2024)
  • Figure 33. Global Atrial Fibrillation Surgery: by Application USD Million (2019-2024)
  • Figure 34. Global Atrial Fibrillation Surgery: by Devices USD Million (2019-2024)
  • Figure 35. South America Atrial Fibrillation Surgery Share (%), by Country
  • Figure 36. Asia Pacific Atrial Fibrillation Surgery Share (%), by Country
  • Figure 37. Europe Atrial Fibrillation Surgery Share (%), by Country
  • Figure 38. MEA Atrial Fibrillation Surgery Share (%), by Country
  • Figure 39. North America Atrial Fibrillation Surgery Share (%), by Country
Some of the key companies/manufacturers profiled in the report
  • Biosense Webster Inc. (United States)
  • Medtronic plc (Ireland)
  • Abbott Laboratories (United States)
  • Boston Scientific Corporation (United States)
  • AtriCure Inc. (United States)
  • Biotronik SE & Co. KG (Germany)
  • Cardiofocus Inc. (United States)
  • Johnsons & Johnson Ltd (United States)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation